We've received your request for NDC00024-5843-05 (described as Sargramostim For Injection), manufactured by Sanofi Pasteur Inc with CAGE code 7V915. This part is registered under NSN 6505-01-654-2233, classified in FSG 65 Medical Dental and Veterinary Equipment and Supplies / FSC 6505 Drugs and Biologicals. Our verification process will confirm traceability through supporting identifiers including NIIN 01-654-2233, NCB code 01 (origin: USA), and INC 47171. Please submit your formal quotation request to proceed.
Thank you for choosing Aerospace Exchange for your NDC00024-5843-05 requirements. We specialize in authenticated aerospace components, offering both NSN-tracked military parts and commercial equivalents, all validated through our rigorous sourcing protocols.
How to Begin the Quotation Process
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-01-654-2233 Item PartTypeName: SARGRAMOSTIM FOR INJECTION | 6505 | 016542233 | M | P | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| U | A | 0 | ||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| 1402758 | 5 | 1 | 5 |
| MRC | Criteria | Characteristic |
|---|---|---|
| FEAT | SPECIAL FEATURES | SARGRAMOSTIM 250 MCG PER VIAL; CONTAINS 250 MCG OF PRESERVATIVE-FREE LYOPHILIZED SARGRAMOSTIM; PACKAGE OF 5 VIALS; SHOULD BE REFRIGIRATED BETWEEN 2-8DEG (36-46 F); DO NOT FREEZE OR SHAKE; FOR SUBCUTANEOUS INJECTION OR IV INFUSION |
| CSGS | ADMINISTRATION | SUBCUTANEOUS AND INTRAVENOUS INFUSION |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.00 MICROGRAMS SARGRAMOSTIM ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| AGXW | PHYSICAL FORM | FREEZE-DRIED POWDER |
| AJCN | PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| CBBL | FEATURES PROVIDED | STERILE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 250.00 MICROGRAMS |
| CSLZ | USUAL DOSE | 250 MCG/M2/DAY FOR 14 DAYS AS A 2-HOUR IV INFUSION; THE DOSE CAN BE REPEEATED AFTER 7 DAYS OFF THERAPY IF ENGRAFTMENT HAS NOT OCCURRED; IF ENGRAFTMENT STILL HAS NOT OCCURRED, A THIRD COURSE OF 500 MCG/M2/DAY FOR 14 DAYS MAY BE TRIED AFTER A |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | LEUKINE (SARGRAMOSTIM) INJ, 250 MCG PER VIAL, 5'S |
| AAC | L |
|---|---|
| Classification Control | U |
| MGMT_CTL | 1-54--- |
| Quantity per pack | 0 |
| Repariability | This is a nonreparable item. if condemned or economically unserviceable, then dispose at the level authorized replace the item. |
| Shelf Life | 24 mo. |
| SOS | Sms |
| Unit of Measure | Pg |
 |
AS9120B and ISO 9001:2015 |
 |
Aviation Suppliers Association Member |
 |
FAA AC 0056B Accredited |
 |
AS 6081:2012 Certification |
 |
ESD S20.20-2014 Certification |
Don’t forget That We offer 24/7 Service, Competitive Prices, and Fast Deliveries. We Hope You'll Make Us Your One-Stop Purchasing Solution!
Request for Quote
